EUVIMEDEUVIMED entdecken
Open Access

Milder presentation of osteogenesis imperfecta type VIII due to compound heterozygosity for a predicted loss-of-function variant and novel missense variant in P3H1 —further expansion of the phenotypic spectrum

Kristen A Mikhail, Elizabeth VanSickle, Linda Z Rossetti

Molecular Case Studies · 2023

DOI: 10.1101/mcs.a006260 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Case Studies, 2023. Verfasst von Kristen A Mikhail und 2 weiteren Autor:innen. Beteiligte Einrichtung: Michigan State University College of Human Medicine, Grand Rapids, Michigan 49503, USA; mikhailk@msu.edu linda.rossetti@corewellhealth.org. Hauptthemen laut MEDLINE: Osteogenesis Imperfecta. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteogenesis imperfecta (OI) is a heritable disorder of bone metabolism characterized by multiple fractures with minimal trauma. Autosomal recessive OI type VIII is associated with biallelic pathogenic variants in P3H1 and classically characterized by skeletal anomalies in addition to significant bone fragility, sometimes presenting with in utero fractures and/or neonatal lethality. P3H1 encodes a collagen prolyl hydroxylase that critically 3-hydroxylates proline residue 986 on the α chain of collagen types I and II to achieve proper folding and assembly of mature collagen and is present in a complex with CRTAP and CypB. Most individuals with OI type VIII have had biallelic predicted loss-of-function variants leading to reduced or absent levels of P3H1 mRNA. The reported missense variants have all fallen in the catalytic domain of the protein and are thought to be associated with a milder phenotype. Here, we describe an infant presenting with five long bone fractures in the first year of life found to have a novel missense variant in trans with a nonsense variant in P3H1 without any other bony anomalies on imaging. We hypothesize that missense variants in the catalytic domain of P3H1 lead to decreased but not absent hydroxylation of Pro986, with preserved KDEL retention signal and complex stability, causing an attenuated phenotype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Osteogenesis ImperfectaHumansExtracellular Matrix ProteinsProteoglycansMolecular ChaperonesCollagenPhenotypeMutation

Stichwörter der Autor:innen

type 1 collagen overmodification

Substanzen

Extracellular Matrix ProteinsProteoglycansMolecular ChaperonesCollagen

Autor:innen und Institutionen

  • Michigan State University College of Human Medicine, Grand Rapids, Michigan 49503, USA; mikhailk@msu.edu linda.rossetti@corewellhealth.org.
  • Division of Medical Genetics and Genomics, Corewell Health, Grand Rapids, Michigan 49503, USA.

Zitieren

APA

Mikhail, K. A., VanSickle, E., & Rossetti, L. Z. (2023). Milder presentation of osteogenesis imperfecta type VIII due to compound heterozygosity for a predicted loss-of-function variant and novel missense variant in P3H1 —further expansion of the phenotypic spectrum. Molecular Case Studies. https://doi.org/10.1101/mcs.a006260

Vancouver

Mikhail KA, VanSickle E, Rossetti LZ. Milder presentation of osteogenesis imperfecta type VIII due to compound heterozygosity for a predicted loss-of-function variant and novel missense variant in P3H1 —further expansion of the phenotypic spectrum. Molecular Case Studies. 2023. doi:10.1101/mcs.a006260

BibTeX
@article{Mikhail2023,
  author = {Mikhail, Kristen A and VanSickle, Elizabeth and Rossetti, Linda Z},
  title = {Milder presentation of osteogenesis imperfecta type VIII due to compound heterozygosity for a predicted loss-of-function variant and novel missense variant in P3H1 —further expansion of the phenotypic spectrum},
  journal = {Molecular Case Studies},
  year = {2023},
  doi = {10.1101/mcs.a006260}
}
Kostenlos starten →